Who owns ASSEMBLY BIOSCIENCES INC?
- Ticker: ASMB
- CUSIP Number: 045396207
Tip: Access positions for across all investors
Analyze quarterly positions in Assembly Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Assembly Biosciences stock
Who bought or sold ASSEMBLY BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Gilead Sciences | 4.5M | $125M | 0% | Mar 2026 |
|
| Farallon Capital Management | 1.2M | $34M | 0% | Mar 2026 |
|
| RA Capital Management | 1.0M | $28M | 0% | Mar 2026 |
|
| Commodore Capital | 1.0M | $28M | 0% | Mar 2026 |
|
| Henderson Group | 849k | $24M | 100% | Mar 2026 |
|
| Paradigm Biocapital Advisors | 665k | $19M | 0% | Mar 2026 |
|
| Vanguard Capital Management | 490k | $14M | 100% | Mar 2026 |
|
| Parkman Healthcare Partners | 411k | $11M | 65% | Mar 2026 |
|
| Point72 Asset Management | 344k | $9.5M | -43% | Mar 2026 |
|
| Blackstone Group | 297k | $8.2M | -7% | Mar 2026 |
|
| Millennium Management | 234k | $6.5M | 138% | Mar 2026 |
|
| BlackRock | 203k | $5.6M | 5% | Mar 2026 |
|
| Stempoint Capital | 185k | $5.1M | 18% | Mar 2026 |
|
| Marshall Wace | 163k | $4.5M | 27% | Mar 2026 |
|
| Adage Capital Partners GP | 161k | $4.5M | 0% | Mar 2026 |
|
| Patient Square Capital | 136k | $3.8M | 7% | Mar 2026 |
|
| Geode Capital Management | 133k | $3.7M | 1% | Mar 2026 |
|
| Schonfeld Strategic Advisors | 121k | $3.3M | 122% | Mar 2026 |
|
| Caption Management | 82k | $2.3M | -23% | Mar 2026 |
|
| HighVista Strategies | 75k | $2.1M | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 72k | $2.0M | 100% | Mar 2026 |
|
| Qube Research & Technologies | 69k | $1.9M | 64% | Mar 2026 |
|
| State Street Corporation | 57k | $1.6M | 7% | Mar 2026 |
|
| Seven Fleet Capital Management | 56k | $1.6M | -24% | Mar 2026 |
|
| Monimus Capital Management | 48k | $1.3M | 26% | Mar 2026 |
|
| GSA Capital Partners | 45k | $1.3M | 255% | Mar 2026 |
|
| Northern Trust | 41k | $1.1M | -1% | Mar 2026 |
|
| Eversept Partners | 41k | $1.1M | -74% | Mar 2026 |
|
| Arrowstreet Capital, Limited Partnership | 39k | $1.1M | 4% | Mar 2026 |
|
| Goldman Sachs Group | 36k | $1.0M | 4% | Mar 2026 |
|
| Jane Street | 35k | $957k | -36% | Mar 2026 |
|
| Morgan Stanley | 33k | $917k | 47% | Mar 2026 |
|
| Susquehanna International | 33k | $914k | -59% | Mar 2026 |
|
| 683 Capital Management | 28k | $773k | 0% | Mar 2026 |
|
| Barclays | 27k | $751k | 9% | Mar 2026 |
|
| Wellington Management Company | 27k | $735k | 100% | Mar 2026 |
|
| Citadel Advisors | 25k | $706k | -23% | Mar 2026 |
|
| Squarepoint Ops | 24k | $661k | 100% | Mar 2026 |
|
| Trexquant Investment | 23k | $631k | -20% | Mar 2026 |
|
| Connor, Clark & Lunn Investment Management | 22k | $604k | 5% | Mar 2026 |
|
| Two Sigma Investments | 21k | $570k | 100% | Mar 2026 |
|
| ADAR1 Capital Management | 20k | $554k | 1% | Mar 2026 |
|
| Palumbo Wealth Management | 20k | $545k | -47% | Mar 2026 |
|
| Federated Investors | 19k | $525k | -26% | Mar 2026 |
|
| Vanguard Portfolio Management | 18k | $492k | 100% | Mar 2026 |
|
| Hudson Bay Capital Management | 17k | $466k | 12% | Mar 2026 |
|
| Renaissance Technologies | 16k | $434k | 69% | Mar 2026 |
|
| Susquehanna Portfolio Strategies | 14k | $391k | 1% | Mar 2026 |
|
| EntryPoint Capital | 12k | $344k | 100% | Mar 2026 |
|
| Brevan Howard Capital Management | 11k | $308k | 100% | Mar 2026 |
|
| Jump Financial | 11k | $303k | 100% | Mar 2026 |
|
| Bank of America Corporation | 11k | $303k | 100% | Mar 2026 |
|
| XTX Topco | 11k | $299k | 100% | Mar 2026 |
|
| Engineers Gate Manager | 9.4k | $262k | -9% | Mar 2026 |
|
| American Century Companies | 9.2k | $254k | 100% | Mar 2026 |
|
| Canada Pension Plan Investment Board | 8.5k | $236k | 143% | Mar 2026 |
|
| OMERS Administration Corporation | 8.1k | $225k | -48% | Mar 2026 |
|
| Virtus Investment Advisers | 7.6k | $210k | 2% | Mar 2026 |
|
| Citigroup | 6.5k | $180k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 4.6k | $128k | 100% | Mar 2026 |
|
| Tower Research Capital | 544.00 | $15k | -10% | Mar 2026 |
|
| UBS Group | 364.00 | $10k | -96% | Mar 2026 |
|
| Northwestern Mutual Wealth Management Company | 260.00 | $7.2k | 0% | Mar 2026 |
|
| Aquatic Capital Management | 220.00 | $6.1k | 100% | Mar 2026 |
|
| Rhumbline Advisers | 190.00 | $5.3k | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 149.00 | $4.1k | 7350% | Mar 2026 |
|
| Advisor Group Holdings | 100.00 | $2.8k | 0% | Mar 2026 |
|
| Fifth Third Bancorp | 57.00 | $1.6k | 100% | Mar 2026 |
|
| EverSource Wealth Advisors | 55.00 | $1.5k | 0% | Mar 2026 |
|
| Hanson McClain Advisors | 29.00 | $804.999400 | -9% | Mar 2026 |
|
| Royal Bank of Canada | 16.00 | $0 | 100% | Mar 2026 |
|
Who sold out of Assembly Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Franklin Resources | Dec 2025 | 211k | $7.2M |
| Superstring Capital Management | Dec 2025 | 65k | $2.2M |
| Eudaimonia Asset Management | Dec 2025 | 30k | $1.0M |
| Sei Investments | Dec 2025 | 18k | $604k |
| Raymond James Financial | Dec 2025 | 13k | $445k |
| Acadian Asset Management | Dec 2025 | 12k | $422k |
| Charles Schwab Investment Management | Dec 2025 | 6.7k | $228k |
| Quadrant Capital | Dec 2025 | 22.00 | $749.001000 |